Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's After-Market Session

Author: Benzinga Insights | November 13, 2025 04:06pm

Gainers

  • Milestone Scientific (AMEX:MLSS) stock moved upwards by 18.6% to $0.45 during Thursday's after-market session. The market value of their outstanding shares is at $28.1 million.
  • Applied Therapeutics (NASDAQ:APLT) shares moved upwards by 6.92% to $0.29. The market value of their outstanding shares is at $131.0 million. As per the press release, Q3 earnings came out today.
  • Reviva Pharmaceuticals (NASDAQ:RVPH) stock increased by 6.63% to $0.58. The company's market cap stands at $55.7 million.
  • Radiopharm Theranostics (NASDAQ:RADX) shares increased by 6.16% to $4.82. The company's market cap stands at $36.4 million.
  • Phio Pharma (NASDAQ:PHIO) shares moved upwards by 5.59% to $1.51. The market value of their outstanding shares is at $9.0 million.
  • Galecto (NASDAQ:GLTO) shares moved upwards by 5.06% to $29.25. The company's market cap stands at $31.3 million.

Losers

  • Immutep (NASDAQ:IMMP) stock declined by 4.3% to $1.76 during Thursday's after-market session. The company's market cap stands at $263.4 million.
  • MSP Recovery (NASDAQ:MSPR) shares decreased by 4.21% to $0.46.
  • Korro Bio (NASDAQ:KRRO) stock decreased by 2.93% to $6.31. The market value of their outstanding shares is at $295.0 million. As per the press release, Q3 earnings came out yesterday.
  • Alkermes (NASDAQ:ALKS) shares decreased by 2.77% to $30.15. The market value of their outstanding shares is at $5.1 billion.
  • enGene Holdings (NASDAQ:ENGN) stock decreased by 2.14% to $8.25. The market value of their outstanding shares is at $444.3 million.
  • Prelude Therapeutics (NASDAQ:PRLD) shares fell 1.99% to $1.48. The company's market cap stands at $83.2 million. The company's, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALKS APLT ENGN GLTO IMMP KRRO MLSS MSPR PHIO PRLD RADX RVPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist